NEUROLOGY 2005;65:586-590
© 2005 American Academy of Neurology
Prevalence and patterns of cognitive impairment in sporadic ALS
G. M. Ringholz, MD, PhD,
S. H. Appel, MD,
M. Bradshaw, PhD,
N. A. Cooke, PhD,
D. M. Mosnik, PhD and
P. E. Schulz, MD
From the Department of Neurology (Dr. Ringholz), Emory University School of Medicine, Atlanta, GA; Department of Neurology (Dr. Appel), The Neurologic Institute, The Methodist Hospital, Houston, TX; Neurology Care Line (Drs. Mosnik and Schulz), Michael E. DeBakey VA Medical Center, Houston, TX; and Department of Neurology (Drs. Appel, Bradshaw, Cooke, Mosnik, and Schulz), Baylor College of Medicine, Houston, TX.
Address correspondence and reprint requests to Dr. Stanley H. Appel, Professor and Chairman, Methodist Neurological Institute, 6501 Fannin St., NB-302, Houston, TX 77030; e-mail: SAppel{at}tmh.tmc.edu
Objective: To investigate the prevalence and nature of cognitive changes associated with sporadic amyotrophic lateral sclerosis (ALS) using a large scale study.
Methods: Consecutive patients with sporadic ALS (n = 279) underwent comprehensive neurologic evaluation and neuropsychological testing. Testing data from normal controls (n = 129) were used for classification and comparison purposes.
Results: On non-motor, non-speed-dependent tasks, 51% of patients with ALS had evidence of cognitive impairment compared to 5% of controls. Cluster analysis suggested four patient subgroups: 49% intact, 32% with mild impairment, 13% with moderate impairment, and 6% with severe impairment. Forty-one patients (15%) met criteria for frontotemporal dementia (FTD). ALS patient subgroups, excluding the intact group, performed significantly lower on tests of executive function and memory than normal controls. Patients with more severe disease also had deficits in confrontation naming. Although memory function declined with increasing severity of overall cognitive impairment, only two patients had the severe memory loss typical of Alzheimer disease. Cognitive impairment was correlated with clinical measures of word-finding, phrase length, and motor programming. Cognitive impairment was not correlated with depression scores or severity or duration of motor or bulbar symptoms. Patients with bulbar vs limb-onset ALS were not different in either level of impairment or pattern of performance.
Conclusions: These data confirm the presence of cognitive impairment in 50% of patients with ALS and particularly implicate executive dysfunction and mild memory decline in the disease process. More severe impairment occurs in a subset of patients with ALS and has features consistent with FTD.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the August 23 issue to find the title link for this article.
The Vicki Appel/MDA ALS clinic is supported by the Muscular Dystrophy Association.
Disclosure: The authors report no conflicts of interest.
Received March 14, 2003. Accepted in final form May 13, 2005.
This article has been cited by other articles:
|
|
|
|
 
T. Van Langenhove, J. van der Zee, K. Sleegers, S. Engelborghs, R. Vandenberghe, I. Gijselinck, M. Van den Broeck, M. Mattheijssens, K. Peeters, P. P. De Deyn, et al.
Genetic contribution of FUS to frontotemporal lobar degeneration
Neurology,
February 2, 2010;
74(5):
366 - 371.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. T. Hu, H. Seelaar, K. A. Josephs, D. S. Knopman, B. F. Boeve, E. J. Sorenson, L. McCluskey, L. Elman, H. J. Schelhaas, J. E. Parisi, et al.
Survival Profiles of Patients With Frontotemporal Dementia and Motor Neuron Disease
Arch Neurol,
November 1, 2009;
66(11):
1359 - 1364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. G. Miller, C. E. Jackson, E. J. Kasarskis, J. D. England, D. Forshew, W. Johnston, S. Kalra, J. S. Katz, H. Mitsumoto, J. Rosenfeld, et al.
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology,
October 13, 2009;
73(15):
1227 - 1233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Steinacker, C. Hendrich, A. D. Sperfeld, S. Jesse, C. A. F. von Arnim, S. Lehnert, A. Pabst, I. Uttner, H. Tumani, V. M.-Y. Lee, et al.
TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Arch Neurol,
November 1, 2008;
65(11):
1481 - 1487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sleegers, N. Brouwers, S. Maurer-Stroh, M. A. van Es, P. V. Damme, P.W.J. van Vught, J. van der Zee, S. Serneels, T. D. Pooter, M. Van den Broeck, et al.
Progranulin genetic variability contributes to amyotrophic lateral sclerosis
Neurology,
July 22, 2008;
71(4):
253 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J. Neurol. Neurosurg. Psychiatry,
January 1, 2008;
79(1):
6 - 11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Lakerveld, B Kotchoubey, and A Kubler
Cognitive function in patients with late stage amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry,
January 1, 2008;
79(1):
25 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Schmolck, D. Mosnik, and P. Schulz
Rating the approachability of faces in ALS
Neurology,
December 11, 2007;
69(24):
2232 - 2235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hammad, A. Silva, J. Glass, J. T. Sladky, and M. Benatar
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS
Neurology,
December 11, 2007;
69(24):
2236 - 2242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S-M Kim, K-M Lee, Y-H Hong, K S Park, J-H Yang, H-W Nam, J-J Sung, and K-W Lee
Relation between cognitive dysfunction and reduced vital capacity in amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry,
December 1, 2007;
78(12):
1387 - 1389.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Wheaton, A. R. Salamone, D. M. Mosnik, R. O. McDonald, S. H. Appel, H. I. Schmolck, G. M. Ringholz, and P. E. Schulz
Cognitive impairment in familial ALS
Neurology,
October 2, 2007;
69(14):
1411 - 1417.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Neumann, L. K. Kwong, D. M. Sampathu, J. Q. Trojanowski, and V. M.-Y. Lee
TDP-43 Proteinopathy in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis: Protein Misfolding Diseases Without Amyloidosis
Arch Neurol,
October 1, 2007;
64(10):
1388 - 1394.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Irwin, C. F. Lippa, and J.M. Swearer
Cognition and Amyotrophic Lateral Sclerosis (ALS)
American Journal of Alzheimer's Disease and Other Dementias,
September 1, 2007;
22(4):
300 - 312.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V. M. Van Deerlin, E. M. Wood, P. Moore, W. Yuan, M. S. Forman, C. M. Clark, M. Neumann, L. K. Kwong, J. Q. Trojanowski, V. M.-Y. Lee, et al.
Clinical, Genetic, and Pathologic Characteristics of Patients With Frontotemporal Dementia and Progranulin Mutations
Arch Neurol,
August 1, 2007;
64(8):
1148 - 1153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Mitsumoto and J. G. Rabkin
Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best"
JAMA,
July 11, 2007;
298(2):
207 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Wicks, S. Abrahams, P. N. Leigh, L. H. Goldstein, Z. Simmons, C. Flaherty-Craig, P. Eslinger, and B. Stephens
A RAPID SCREENING BATTERY TO IDENTIFY FRONTAL DYSFUNCTION IN PATIENTS WITH ALS
Neurology,
July 3, 2007;
69(1):
118 - 120.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Seelaar, H. Jurgen Schelhaas, A. Azmani, B. Kusters, S. Rosso, D. Majoor-Krakauer, M. C. de Rijik, P. Rizzu, M. ten Brummelhuis, P. A. van Doorn, et al.
TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations
Brain,
May 1, 2007;
130(5):
1375 - 1385.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Murphy, R. G. Henry, S. Langmore, J. H. Kramer, B. L. Miller, and C. Lomen-Hoerth
Continuum of Frontal Lobe Impairment in Amyotrophic Lateral Sclerosis
Arch Neurol,
April 1, 2007;
64(4):
530 - 534.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gauthier, A. Vignola, A. Calvo, E. Cavallo, C. Moglia, L. Sellitti, R. Mutani, and A. Chio
A longitudinal study on quality of life and depression in ALS patient-caregiver couples
Neurology,
March 20, 2007;
68(12):
923 - 926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Murphy, R. Henry, and C. Lomen-Hoerth
Establishing Subtypes of the Continuum of Frontal Lobe Impairment in Amyotrophic Lateral Sclerosis
Arch Neurol,
March 1, 2007;
64(3):
330 - 334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D.M. Mezzapesa, A. Ceccarelli, F. Dicuonzo, A. Carella, M.F. De Caro, M. Lopez, V. Samarelli, P. Livrea, and I.L. Simone
Whole-Brain and Regional Brain Atrophy in Amyotrophic Lateral Sclerosis
AJNR Am. J. Neuroradiol.,
February 1, 2007;
28(2):
255 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Flaherty-Craig, P. Eslinger, B. Stephens, and Z. Simmons
A rapid screening battery to identify frontal dysfunction in patients with ALS
Neurology,
December 12, 2006;
67(11):
2070 - 2072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Wicks, S. Abrahams, P. N. Leigh, T. Williams, and L. H. Goldstein
Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy.
Neurology,
November 14, 2006;
67(9):
1718 - 1719.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Talbot and O. Ansorge
Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R182 - R187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Strong
ALS--Not What We Thought.
Arch Neurol,
March 1, 2006;
63(3):
319 - 320.
[Full Text]
[PDF]
|
|
|
|
|
|
|
ALS Is Not Just a Motor Neuron Disease
Journal Watch Psychiatry,
October 5, 2005;
2005(1005):
7 - 7.
[Full Text]
|
|
|
|
